Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration

Clinical trial NCT06890026 · COMPLETED

Trial details

NCT number: NCT06890026
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascular Age-Related Macular Degeneration (nAMD)Treatment-naïve

Start date: 2024-11-15
Primary completion: 2026-03-01
Enrollment: 742

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.